Bright Minds Biosciences (DRUG) Depreciation & Amortization (CF) (2022 - 2026)
Bright Minds Biosciences' (DRUG) quarterly Depreciation & Amortization (CF) came in at $14439.0 in Q1 2026, down 7.84% YoY from $15667.4 in Q1 2025, and up 1.75% on a QoQ basis from $14190.4 in Q4 2025.
Powered by 
Analysis
Bright Minds Biosciences (DRUG) Depreciation & Amortization (CF) (2022 - 2026) Analysis & Trends
Bright Minds Biosciences (DRUG) has 5 years of Depreciation & Amortization (CF) data on file, last reported at $14439.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Bright Minds Biosciences | 449.62 Mn | 227.08 Mn | - | 14,066.68 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14,066.68 |
| Mar 31, 2026 | 14,439.00 |
| Dec 31, 2025 | 14,190.42 |
| Sep 30, 2025 | 12,359.33 |
| Jun 30, 2025 | 11,435.53 |
| Mar 31, 2025 | 15,667.38 |
| Dec 31, 2024 | 15,414.38 |
| Sep 30, 2024 | 49,128.51 |
| Jun 30, 2024 | -21,851.60 |
| Mar 31, 2024 | 13,441.15 |
| Dec 31, 2023 | 13,304.64 |
| Sep 30, 2023 | 13,510.29 |
| Jun 30, 2023 | 13,484.27 |
| Mar 31, 2023 | 13,398.12 |
| Dec 31, 2022 | 13,343.16 |